Interning at WHO has been a huge privilege. For example, on day one of my arrival, I was able to attend the internal briefing given by Dr. Margaret Chan, WHO Director-General, on the H1N1 Pandemic. Since then, I have watched personnel work around the clock to understand this disease within the global public health context as well as, evaluate how the International Health Regulations apply in the “attainment of the highlights possible level of health” for mankind.
I deliberately refused to post on the subject due to the amount of noise that was created by Social Media on this matter; however now that news have focused towards Iran and the death of Michael Jackson, I would like you to create your own conclusion on the importance of the subject.
The following two pieces form the picture from Evidence Based Medicine to News to Death Ratio and may help you formulate the prioritization of healthcare delivery at the global level.
Please let me know how you feel about its importance.
How can we make it possible for charities and foundations to report failure anonymously; particularly when failure results in future lack of funding?
Can a model of “fail fast! Fail cheap! Learn for big success” be instituted in funding and healthcare agencies?
Are there cultural differences between entrepreneurial spirit responsible for system differences between the US and the UK? Is there a particular aspect of the NHS that hinders/helps innovation?
What can we learn from the DeDomble project where software for appendicitis diagnosis and treatment was more effective than humans yet still failed in adoption in the US? (I looked for a reference but was unable to find one) & Why is it that thirty years later from DeDomble’s lesson, it is nearly impossible to learn about his lessons learned in the design and implementation of an effective treatment option?
What are the specific psychological components of knowledge transfer in the failure of health system and project innovation?
What can we learn from the deployment of the Open Source model for knowledge transfer in the failure of health innovation?
Are there system differences between the NHS (i.e. consumer-based models) vs. Venture Capitalist models in the implementation of health innovation?
What role does intellectual property governance play in innovation uptake and success?
What are the differences in health innovation uptake and buyout by managers vs. clinicians?
Can we formulate incentives through governance when a project fails, or members of a team know project deployment will fail or are unable to act?
How does market share and industry competition affect knowledge transfer in failure of health innovation?
Are current collaborative practices fostering failure in health innovation?
What are the differences between healthcare professionals and managers between risk and customer satisfaction from at the health system and new project implementation level?
Where, how and why should we share failure in health innovation? & What sort of information quality standard should we strive for?
What sort of clinical entrepreneurship is ideal in a system like the NHS?
How can exit interviews be used for knowledge acquisition and transfer in creating an open source venue for failure of health innovation?
How do patents and corresponding expiry dates affect perceptions towards success in health innovation?
What role does the team room environment play in fostering health innovation? & How can we adapt a social system to innovation leaders like 3M and Google.
How do we measure the difference between Hospital performance (i.e. monetarily) and hospital health (i.e. motivational leadership/ spirit de corps) as the driver of failure or success in innovation?
How can we foster input from other team members when we large team meetings and consider them waste of time?
Is there a best practice method to foster quick and dirty failure in health innovation? & Should funding models be changed accordingly?
What sort of global and local guidelines should be established for sharing failure in health innovation?
How do we deal with KT of failures in unethical research that was aimed at health innovation?
What is innovation and how can we evaluate it on a framework with success
Should a taxonomy of failure be developed? & How can it be used in knowledge transfer of health innovation?
What is the role of sociocultural values on the failure of healthcare innovation and knowledge transfer within it?
Are there any more thoughts or themes that you would like to add?
Last weekend I had the pleasure of being invited to one of the most innovative health conferences I have ever attended – HealthCampUK.
The event begins with a few Lightning Talks, where after being recorded on video, the audience chooses where they will spend their time thinkering for the remainder of the event.
I was fortunate enough to be selected as one of the moderators based on my talk on Open Sourcing Failure of Health Innovation. Below you will find this talk and the theme tags from the moderated session.
Theme Tags:
Reputation
Liability
Entrepreneurial Spirit
NHS
Repository
Anonymity
Timing
Perception
Environment
Transparency
Open Source Model
Knowledge Transfer
Ladder/Chain of Command
Transformation
Intellectual Property
Governance
Time
Freedom of Information
Infrastructure
Economic Climate
Information
Best Practice
Culture
Face time
Culture Empowerment
Local Failure
Quicker, Better, More Effectively
I would like to take this opportunity to thank Dr Mohammad Al-Ubaydli, the organizer of HealthCampUK.
If you would like to contribute to these tags, please leave a comment or contact me so they can be added.
Last year, Prof. Sir. Michael Rawlins delivered a fascinating lecture where he explains the many strengths and weaknesses of randomized controlled trials and why these must and will change in the future.
This is must know information on Evidence Based Medicine for all physicians, medical students, and allied health care practitioners.
I hope you enjoy it as much as I did.
Harveian Oration 2008
Please feel free to leave a comment or send suggestions.
Understanding the background literature is essential for any researcher or public health practitioner. Today, with all the hype on the potential of mhealth, there’s a lot of noise and few people really understand the technical, clinical, and societal implications of mobiles; especially when according to the ITU, the ratio of mobiles to people around the world is 1:6, a figure difficult to ignore when planning effective public health interventions.[1]
I believe the two following reports are a wonderful introduction to the subject. I hope you enjoy them as much as I did.
I am too often asked “why do you even bother wasting your time with Twitter?” However, as an early adopter I still remember the day when I was socked with information overload of the few people I followed.
Today, I am followed by and follow over four hundred tweeps and cannot imagine a day without greeting, collaborating, and tinkering along with my twitter gang. For those of you open minded types, I believe the following two pieces nicely describe the impact Twitter can have in Medicine and Public Health.
NY Times Columnist Dr. Pauline Chen’s Medicine in the Age of Twitter
